Summary
Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products for the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. The company distributes its products through direct sales force; independent distributors, drug wholesalers acting as sales agents and specialty pharmacies or other alternate site providers. It has wide spread operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.
Baxter International Inc (BAX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Baxter International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Baxter International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Baxter International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Baxter International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Baxter International Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Baxter International Acquires Ostene Product Line From Ceremed 12
Private Equity 13
Third Point Acquires 7% Stake in Baxter International 13
Partnerships 13
Baxter International Enters into Licensing Agreement with Ramot 13
AWAK Technologies Enters Into Licensing Agreement With Baxter International For Dialysis Technology 14
Rockwell Medical Enters into Co-Marketing Agreement with Baxter Healthcare 15
Debt Offering 16
Baxter International Prices Public Offering of 1.3% Notes Due 2025 for USD668.2 Million 16
Baxter Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 17
Baxter Completes Public Offering Of Notes Due 2018 For US$750 Million 19
Baxter Completes Public Offering Of Notes Due 2043 For US$500 Million 20
Baxter Completes Public Offering Of Notes Due 2016 For US$500 Million 22
Baxter Completes Public Offering Of Notes Due 2014 For US$500 Million 24
Baxter International Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 25
Asset Transactions 26
Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 26
Sunshine Heart Acquires Aquadex Product Line from Baxter 27
Nikkiso Completes Acquisition Of Continuous Renal Replacement Therapy Business Of Baxter International For US$38.8 Million 28
Acquisition 29
Baxter Completes Acquisition Of Gambro, Dialysis Products Maker, For US$4 Billion 29
Baxter International Acquires Remaining 60% Stake In Sigma International General Medical Apparatus For US$90 Million 31
Baxter International Completes Acquisition Of Synovis Life Technologies For US$325 Million 32
Baxter International Completes Acquisition Of Baxa For US$380 Million 34
Baxter International Completes Acquisition Of Prism Pharma For US$338 Million 35
Terumo Completes Acquisition Of CaridianBCT From Gambro 36
Baxter International Inc - Key Competitors 38
Key Employees 39
Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 47
Strategy And Business Planning 47
May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 47
Financial Announcements 48
Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 48
Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 50
Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 52
Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 53
Apr 26, 2016: Baxter Reports First Quarter 2016 Results and Provides Updated Financial Outlook for Full-Year 2016 55
Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook 57
Corporate Communications 59
Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 59
May 05, 2016: Baxter Announces Appointment of Interim President for Its Renal Business 60
Apr 14, 2016: Baxter-Supported Community Partnership in India Launches Mobile Health Application to Expand Healthcare for Women and Children 61
Product News 63
Jun 01, 2017: Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care 63
Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 64
Nov 21, 2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care 65
Nov 17, 2016: Baxter to Present 24 Abstracts at ASN Kidney Week 2016 Focused on Elevating the Standard of Care For Dialysis Patients Globally 66
Jul 27, 2016: Baxter Presents New Evidence Demonstrating REVACLEAR Dialyzer Associated with Lower Drug Use During Hemodialysis 67
Mar 15, 2016: Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 68
Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter 69
Clinical Trials 70
Mar 15, 2016: Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 70
Other Significant Developments 71
Jun 26, 2017: Baxter Announces DoseEdge Bi-Directional Integration with Epic in the Pharmacy 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72
List of Tables
Baxter International Inc, Medical Equipment, Key Facts, 2016 1
Baxter International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Baxter International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Baxter International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Baxter International Inc, Deals By Market, 2011 to YTD 2017 9
Baxter International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Baxter International Acquires Ostene Product Line From Ceremed 12
Third Point Acquires 7% Stake in Baxter International 13
Baxter International Enters into Licensing Agreement with Ramot 13
AWAK Technologies Enters Into Licensing Agreement With Baxter International For Dialysis Technology 14
Rockwell Medical Enters into Co-Marketing Agreement with Baxter Healthcare 15
Baxter International Prices Public Offering of 1.3% Notes Due 2025 for USD668.2 Million 16
Baxter Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 17
Baxter Completes Public Offering Of Notes Due 2018 For US$750 Million 19
Baxter Completes Public Offering Of Notes Due 2043 For US$500 Million 20
Baxter Completes Public Offering Of Notes Due 2016 For US$500 Million 22
Baxter Completes Public Offering Of Notes Due 2014 For US$500 Million 24
Baxter International Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 25
Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 26
Sunshine Heart Acquires Aquadex Product Line from Baxter 27
Nikkiso Completes Acquisition Of Continuous Renal Replacement Therapy Business Of Baxter International For US$38.8 Million 28
Baxter Completes Acquisition Of Gambro, Dialysis Products Maker, For US$4 Billion 29
Baxter International Acquires Remaining 60% Stake In Sigma International General Medical Apparatus For US$90 Million 31
Baxter International Completes Acquisition Of Synovis Life Technologies For US$325 Million 32
Baxter International Completes Acquisition Of Baxa For US$380 Million 34
Baxter International Completes Acquisition Of Prism Pharma For US$338 Million 35
Terumo Completes Acquisition Of CaridianBCT From Gambro 36
Baxter International Inc, Key Competitors 38
Baxter International Inc, Key Employees 39
Baxter International Inc, Other Locations 40
Baxter International Inc, Subsidiaries 40
